+ 2.69
+ 1.88%

UPDATE: MKM Maintains Neutral On Finisar, Lowers Target To $22 'to reflect increasing uncertainties about Chinese regulatory approval for the merger with IIV'

September 5, 2019 12:27 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

Should Investors Buy Lumentum After Monday's Plunge? The Street Debates

BlueFin Talks VCSEL 'Drama' Ahead Of Q3 Earnings Season

UPDATE: BlueFin On Apple Exploring Internal VCSEL Development: 'It appears to us that this is more of a call to arms by AAPL for FNSR, IIVI, and LITE to increase production to meet the demand – or else face the consequences'

BlueFin Earlier Note On VCSELs Says, 'Our latest checks reveal Lumentum has actually received increased orders recently. Competitors II-VI, Finisar continue to focus on securing second-source positioning'